Multiple Sclerosis Drug Market Share

The North America multiple sclerosis drug market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. A few variables that are anticipated to drive the expansion of the market in North America include an increase in the global burden of multiple sclerosis among the population and a higher probability of women getting multiple sclerosis. In the United States, every week, around 200 new cases are added to the list of multiple sclerosis patients. Moreover, in 2019, nearly 400,000 people were affected by it. In North America, there are around 140 cases per 100,000 population and out of them, about 70% of patients are women, further, in the past 30 years, the ratio of women to men has jumped from 2:1 to 3:1. Furthermore, the development in the healthcare sector in North America is to elevate the growth of the market in the region. At the end of 2019, the total expenditure on health facilities in the U.S. was worth nearly 18% of the U.S. gross domestic product (GDP), and it is expected to total USD 6 trillion annually by 2028.